Artboard article
- BARRONS (2020)

The company said it is sponsoring a 400-patient randomized trial to confirm whether the drug Olumiant can moderate Covid symptoms.

—-

“... The idea that Eli Lilly ’s arthritis drug Olumiant might help Covid-19 patients emerged from an artificial-intelligence survey of approved drugs...

saved by: FoundryBase
updated 16 days ago
Visibility: Public (all visitors)


Comments

No comments yet. Be the first to comment!

MORE RESOURCES FROM SOURCE

More in FoundryBase from   https://barrons.com

Related Chunks

Related chunks with this resource

This Article can be found in 3 chunks